29 results
Glucose-lowering medication in type 2 diabetes - Algorithm

#Diabetes #Medications #Algorithm #Pharmacology #Pharmacotherapy #Hypoglycemic #Management #Endocrinology
Glucose-lowering medication ... type 2 diabetes - Algorithm ... #Diabetes #Medications ... #Algorithm #Pharmacology ... #Hypoglycemic #Management
Asthma Medications and Mechanism of Action

#Asthma #Medications #Drugs #Pulmonary #Pharmacology #Management #Treatment
Asthma Medications ... Action #Asthma #Medications ... #Drugs #Pulmonary ... #Pharmacology # ... Management #Treatment
HIV Antiretroviral Regimen Components 
Dual NRTI Backbone + Third Agent 

The general HIV antiretroviral medication regimen
Antiretroviral Regimen Components ... antiretroviral medication ... regimen includes 3 components ... #HIV #Pharmacology ... #Management
Treatment Algorithm for Pulmonary Hypertension

#Pulmonary #Hypertension #PAH #Treatment #Management #Algorithm #Medications
Treatment Algorithm ... for Pulmonary Hypertension ... #Pulmonary # ... PAH #Treatment #Management ... #Algorithm #Medications
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
For most indications ... #management #algorithm ... #pharmacology # ... treatment #medications
Deprescribing algorithm for proton pump inhibitors

To support clinicians in employing the recommendations outlined in the guideline,
Deprescribing algorithm ... deprescribing algorithm ... This algorithm helps ... life changes, medications ... #Management #Geriatrics
Prostanoid prescribing and management in Pulmonary Arterial Hypertension (PAH)
Oral Prostanoids:
 - Selexipag
 - Treprostinil
Inhaled Prostanoids
 -
prescribing and management ... in Pulmonary Arterial ... #prescribing #Pulmonary ... #Algorithm #treatment ... #pharmacology
“Step by Step” – the new kid on the block – aims to risk stratify this
for each of the components ... of the algorithm ... #Diagnosis #Management ... #Pediatrics #Peds ... Infant #StepByStep #Algorithm
Management of interstitial lung disease (ILD)-associated with systemic sclerosis (SSc)

Therapeutic indication: absolute decline in FVC >10%
Management of interstitial ... systemicsclerosis #SSc #pulmonary ... #indications #management ... #treatment #algorithm
Biologic therapy for eosinophilic asthma 
• Mepolizumab (Nucala) 
  • Anti-lL-5, 100 mg SQ q4
Biologic #therapy #Medications ... #pharmacology # ... pulmonary #management